Modification of topoisomerase I activity by glucose and by O-GlcNAcylation of the enzyme protein

Glycobiology

Volumn 17, Issue 12, 2007, Pages 1357-1364

  Noach, Noa ^a   Segev, Yael ^a   Levi, Itzhak ^a   Segal, Shraga ^a   Priel, Esther ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

DNA relaxation; Glucose; O GlcNAc; O GlcNAc transferase (OGT); Topoisomerase I

Indexed keywords

DNA TOPOISOMERASE; GLUCOSE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINE TRANSFERASE; TRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CORRELATION ANALYSIS; DNA TRANSCRIPTION; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; ENZYME MODIFICATION; ENZYME REGULATION; GENE EXPRESSION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM;

ACETYLGLUCOSAMINE; ALLOXAN; ANIMALS; CELL LINE; CELL NUCLEUS; DNA; DNA TOPOISOMERASES, TYPE I; FABACEAE; GLUCOSE; HEXOSAMINIDASES; IMMUNOPRECIPITATION; KIDNEY; LECTINS; MICE; MICE, INBRED BALB C; SEPHAROSE; SWINE;

SUS;

EID: 36249009615     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwm105     Document Type: Article

References (51)

1. Auer B, Vosberg H, Buhre U, Klocker H, Hirsch-Kauffman M, Schweiger M. 1982. Intracellular distribution of DNA topoisomerase I in fibroblast from patient with Fanconi's anemia. Hum Genet. 61:369-371.
2. Bendetz-Nezer S, Gazit A, Priel E. 2004. DNA topoisomerase I as one of the cellular targets of certain tyrphostin derivatives. Mol Pharmacology. 66:627-634.
3. Bonnin S, Besson F, Gelhausen M, Chierici S, Roux B. 1999. A FTIR spectroscopy evidence of the interactions between wheat germ agglutinin and N-acetylglucosamine residues. FEBS Lett. 456:361-364.
4. Brill SJ, DiNardo S, Voelkel-Meiman K, Sternglanz R. 1987. Need for DNA topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA. Nature. 326:414-416.
5. Champoux J. 2001. DNA topoisomerases: Structure, Function, and mechanism. Annu Rev Biochem. 70:369-413.
6. Comer FI, Hart G. 2001. Reciprocity between O-GlcNAc and O-Phosphate on the Carboxyl Terminal Domain of RNA polymerase II. Biochemistry. 46:7845-7852.
7. Datta B, Ray M, Chakrabarti D, Wylie D, Gupta N. 1989. Glycosylation of eukaryotic peptide chain initiation factor2 (eIF-2)-associated 67-kDa polypeptide (p67) and its possible role in the inhibition of eIF-2 kinase-catalyzed phosphorylation of the eIF-2 alpha-subunit. J Biol Chem. 264:20620-20624.
8. Dauphinee S, Ma M, Too C. 2005. Role of O-linked-b-N-Acetylglucosamine Modification in the subcellular distribution of alpha4 phosphoprotein and SP1 in rat lymphoma cells. J Cell Biochem. 96:579-588.
9. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Browillee M. 2001. Hyperglycemia inhibits endodhelial nitric oxide synthase activity by postranslational modification at the Akt site. J Clin Invest. 108:1341-1348.
10. Forterre P, Gribaldo S, Gadelle D, Serre M. 2007. Origin and evolution of DNA topoisomerases. Biochimie. 89:427-446.
11. Gao Y, Miyazaji J-I, Hart GW. 2003. The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 [beta]-cells. Archives of Biochemistry and Biophysics. 415:155-163.
12. Gao Y, Wells L, Comer FI, Parker GJ, Hart GW. 2001. Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins. Cloning and characterization of a neutral, cytosolic beta-N-Acetylglucosaminidasefrom human brain. J Biol Chem. 276:9838-9845.
13. Garcia-Carbonero R, Supko J. 2002. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecines. Clin Cancer Res. 8:641-661.
14. Hanover J, Cohen C, Willingham M, Park M. 1987. O-linked N-acetylglucosamine is attached to proteins of the nuclear pore. Evidence for cytoplasmic and nucleoplasmic glycoproteins. J Biol Chem. 262:9887-9894.
15. InnOc Han MDR, Jeffrey E Kudlow. 1998. Interaction of the transcription factor Sp1 with the nuclear pore protein p62 requires the C-terminal domain of p62. Journal of Cellular Biochemistry. 68:50-61.
16. Khobta A, Ferri F, Lotito L, Montecucco A, Rossi R, Capranico G. 2006. Early Effects of Topoisomerase I Inhibition on RNA Polymerase II Along Transcribed Genes in Human Cells. Journal of Molecular Biology. 357:127-138.
17. Konrad R, Zhang F, Hale J, Knierman M, Decker G, Kudlow J. 2002. Allox́an is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem Biophys Res Commun. 293:207-212.
18. Kreppel LK, Blomberg MA, Hart GW. 1997. Dynamic Glycosylation of Nuclear and Cytosolic Proteins. Cloning and characterization of a unique O-GlcNAc Transferase with multiple tetratricopeptide repeats. J Biol Chem. 272:9308-9315.
19. Leppard J, Champoux J. 2005. Human DNA topoisomerase I:rElaxation, rols, and damage control. Chtomosoma. 114:75-85.
20. Li T, Liu L. 2000. Tumor cell death induced by topoisomerase-targeting drugs. Ann Rev Pharmacol Toxicol. 41:53-77.
21. Liu J, Marchase R, Chatham J. 2007. Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediared via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels. J Mol Cardiol. 42:177-185.
22. Love D, Hanover J. 2005. The hexosamine signaling pathway:dEciphering the "O-GlcNac code". Sci STKE, 312, re13.
23. Lubas WA, Frank DW, Krause M, Hanover JA. 1997. O-Linked GlcNAc Transferase Is a Conserved Nucleocytoplasmic Protein Containing Tetratricopeptide Repeats. J Biol Chem. 272:9316-9324.
24. Lubas WA, Hanover JA. 2000. Functional Expression of O-linked GlcNAc: Transferase. Domain structure and substrate specificity. J Biol Chem. 275:10983-10988.
25. Macauley MS, Whitworth GE, Debowski AW, Chin D, Vocadlo DJ. 2005. O-GlcNAcase Uses Substrate-assisted Catalysis: Kinetic analysis and development of highly selective mechanism-inspired-inhibitors. J Biol Chem. 280:25313-25322.
26. Majumdar G, Harmon A, Candelaria R, Martinez-Hernandez A, Raghow R, Solomon SS. 2003. O-glycosylation of Sp1 and transcriptional regulation of the calmodulin gene by insulin and glucagon. Am J Physiol Endocrinol Metab. 285, E584-591.
27. Majumdar G, Wright J, Markowitz P, Martinez-Hernandez A, Raghow R, Solomon SS. 2004. Insulin Stimulates and Diabetes Inhibits O-Linked N-Acetylglucosamine Transferase and O-Glycosylation of Sp1. Diabetes. 53:3184-3192.
28. Medina L, Grove K, Haltiwanger R. 1998. SV40 large T antigen is modified with O-linked N-acetylglucosamine but not with other forms of glycosylation. Glycobiology. 8:383-391.
29. Merino A, Madden KR, Lane WS, Champoux JJ, Reinberg D. 1993. DNA toppisomerase I is involved in both repression and activation of transcription. Nature. 365:227-232.
30. Morham S, Kluckman K, Voulomanos N, Smithies O. 1996. Targeted disruption of the mouse topoisomerase I gene by camptotecin selection. Mol Cell Biol. 16:6804-6809.
31. Parker GJ, Lund KC, Taylor RP, McClain DA. 2003. Insulin Resistance of Glycogen Synthase Mediated by O-Linked N-Acetylglucosamine. J Biol Chem. 278:10022-10027.
32. Plaschkes I, Silverman F, Priel E. 2005. DNA topoisomerase I in the mouse central nervous system: Age and Sex dependence. J Comp Neur. 493:357-369.
33. Pommier Y, Poruquier P, Fan Y, Strumberg D. 1998. Mechanism of action of eukaryotic DNA topoisomerase I and drug targeted to the enzyme. Biochem Biophys Acta. 1400:83-86.
34. Pommier Y, Pourquier P, Urasaki Y, Wu J, Laco GS. 1999. Topoisomerase I inhibitors: Selectivity and cellular resistance. Drug Resistance Updates. 2:307-318.
35. Ray M, Datta B, Chakraborty A, Chattopadhyay A, Meza-Keuthen S, Gupta N. 1992. The Eukaryotic Initiation Factor 2-Associated 67-kDa Polypetide (p67) Plays a Critical Role in Regulation of Protein Synthesis Initiation in Animal Cells. PNAS. 89:539-543.
36. Roca J. 1995. The mechanism of DNA topoisomerases. Trends Biochem Schi. 20:156-160.
37. Roos M, Su K, Baker J, Kudlow J. 1997. O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol Cell Biol. 17:6412-6480.
38. Sambrook J, Fritch E, Maniatis T. 1989. Molecular Cloning: A laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor NY.
39. Shykind B, Kim J, Stewart L, Champoux J, Sharp P. 1997. Topoisomerase I enhances TFIID-TFIIA complex assembly during activation of transcription. Genes Dev. 11:397-407.
40. Takakura Y, Morita T, Fujikawa M, Hayashi M, Sezaki H, Hashida M, Borchardt RT. 1995. Characterization of LLC-PK1 Kidney Epithelial Cells as anin Vitro Model for Studying Renal Tubular Reabsorption of Protein Drugs. Pharmaceutical Research. 12:1968-1972.
41. Towle H. 2005. Glucose as a regulator of eukaryotic gene transcription. Trends in Endocrinology and Metabolism. 16:489-494.
42. Vosseller K, Sakabe K, Wells L, Hart GW. 2002. Diverse regulation of protein function by O-GlcNAc: A nuclear and cytoplasmic carbohydrate post-translational modification. Current Opinion in Chemical Biology. 6:851-857.
43. Vosseller K, Wells L, Lane MD, Hart GW. 2002. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. PNAS. 99:5313-5318.
44. Walgren JLE, Vincent TS, Schey KL, Buse MG. 2003. High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin. Am J Physiol Endocrinol Metab. 284:E424-434.
45. Wang JC. 1996. DNA topoisomerases. Annu Rev Biochem. 65:635-692.
46. Wang JC. 2002. Cellular roles of DNA topoisomerases:a molecular perspective. Nature Reviews Mollecular Cell Biology. 3:430-440.
47. Wu A, Wu J, Song S, Tsai M, Herp A. 1998. Studies on the binding of wheat germ agglutinin (Tricum vulgaris) to O-glycans. FEBS Lett. 440:315-319.
48. Yu D, Khan E, Khaleque MA, Lee J, Laco G, Kohlhagen G, Kharbanda S, Cheng Y-C., Pommier Y, Bharti A. 2004. Phosphorylation of DNA Topoisomerase I by the c-Abl Tyrosine Kinase Confers Camptothecin Sensitivity. J Biol Chem. 279:51851-51861.
49. Zachara N, Hart G. 2002. The emerging significance of O-GlcNAc in cellular regulation. Chem Rev. 102:431-438.
50. Zachara N, Hart G. 2004. O-GlcNAc a sensor of cellular state: The role of nucleplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochem Biophys Acta. 1673:13-28.
51. Zhang H, Wang JC, Liu LF. 1988. Involvement of DNA Topoisomeras I in Transcription of Human Ribosomal RNA Genes. PNAS. 85:1060-1064.